All Updates

All Updates

icon
Filter
M&A
Kalera PLC completes separation from international assets
Vertical Farming
Jan 30, 2023
This week:
Funding
EKORE raises EUR 1.3 million (~ USD 1 million) in seed funding to strengthen platform
Digital Twin
Dec 20, 2024
Funding
Culina Health raises USD 7.9 million in Series A funding to expand offerings and expand team
Functional Nutrition
Dec 19, 2024
FDA approval
ViGeneron receives IND clearance for VG801 gene therapy
Cell & Gene Therapy
Dec 19, 2024
Product updates
Reflex Aerospace ships first commercial satellite SIGI
Next-gen Satellites
Dec 19, 2024
Partnerships
Vast partners with SpaceX for two private astronaut missions to ISS
Space Travel and Exploration Tech
Dec 19, 2024
Management news
Carbios appoints Philippe Pouletty as interim CEO amid plant delay
Waste Recovery & Management Tech
Dec 19, 2024
Funding
BlueQubit raises USD 10 million in seed funding to develop quantum platform
Quantum Computing
Dec 19, 2024
FDA approval
Arbor Biotechnologies receives FDA clearance for ABO-101 IND application
Human Gene Editing
Dec 19, 2024
Partnerships
Funding
Personalis partners with Merck and Moderna for cancer therapy development and investment
Precision Medicine
Dec 19, 2024
Partnerships
COTA partners with Guardant Health to develop clinicogenomic data solutions for cancer research
Precision Medicine
Dec 19, 2024
Vertical Farming

Vertical Farming

Jan 30, 2023

Kalera PLC completes separation from international assets

M&A

  • Kalera PLC, a Florida-based hydroponic vertical farming operator, announced its Kalera International business has been acquired by Netherlands-based indoor farming company Growy Holdings BV during the court-supervised process in Germany over Kalera GmbH.

  • The sale includes its German headquarters, a farm in Kuwait, and a farm in Singapore which is under construction. This uncoupling of the international business will allow Kalera to focus all its efforts and capital towards becoming a leading vertical farming operator in the US with accelerated long-term growth in loose-leaf and whole-head product segments.

  • Following the separation, Kalera would retain the irrevocable, perpetual, and sublicensable right and license to Kalera GmbH’s intellectual property excluding &ever, Hydroponics, and HappyNest trademarks which were owned by Kalera GmbH prior to the acquisition.

  • Net proceeds of the sale will be used to partially offset Kalera’s outstanding secured convertible bridge promissory note and towards covering the expenses of the court-supervised process. Further, the company will continue its efforts of divesting its seed genetics business, Vindara–in order to make Kalera’s cash flow positive–which is expected to close before the end of Q1 2023.

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.